NCT03208387Active, not recruiting
Understanding the Late Effects of Surviving a Pediatric Brain Tumor
Biological Substrates of Impaired Neurocognitive Functioning: Understanding the Late Effects of Surviving a Pediatric Brain Tumor
Source: ClinicalTrials.gov · Last updated 2 Jul 2026
Brief summary (registry, in English)
The goal of this study is to learn about the cognitive and behavioral functioning of children being treated for cancer.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 42 (actual)
- First submitted
- 29 Jun 2017
- Start date
- 28 Jun 2017
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Diseases
- Childhood cancers
- NCT number
- NCT03208387
What you commit to
- Study type: Observational
- Participants enrolled: 42
- From 28 Jun 2017 to the primary completion date, 30 Jun 2027
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- As per self or parent report or medical record, currently taking medications that have CNS effects (i.e., antidepressants, neuroleptics, anti-seizure medications, drugs that affect blood pressure or heart rate, alpha-agonists, adrenergic blockers, lithium, sedating antihistamines, and some medications for the treatment of asthma).
Other
- All Participants:
- Full Scale IQ as documented to be below a standard score of \<70 based upon the study IQ assessment completed after consent.
- As per self or parent report, completed any portion of the neuropsychological battery used in this study within the last year.
- MRI contraindications (e.g., implanted ferromagnetic devices, claustrophobia) as per radiology clinical operating procedures.
- As per self or parent report, non-fluency in English language as demonstrated by current educational placement in a non-English-speaking classroom setting.
Who the study is looking for
- Children Treated for Posterior Fossa Tumors:
- As per medical record or clinical report, successfully completed all medical treatment for either an M0 posterior fossa medulloblastoma without dissemination or posterior fossa low-grade astrocytoma without relapse or evidence of residual disease.
- For medulloblastoma survivors only: Previously treated with gross total resection (GTR), craniospinal irradiation with conformal posterior fossa boost radiotherapy (CSI + Boost) and chemotherapy
- For low grade astrocytoma survivors only: Previously treated with gross total resection ONLY (no chemotherapy or radiotherapy).
- As per medical record or clinician report, between 1-10 years post completion of their medical treatment for their posterior fossa brain tumor.
- Subject is between the ages of 6 through 16 years at time of consent.
- As per medical record or parent report, subject is able to tolerate an MRI without sedation.
- Healthy Control Participants:
- No major medical illness, as determined by medical interview by study physician.
- As per parent report, subject is between the ages of 6 through 16 years at time of consent.
- As per parent report, subject is able to tolerate an MRI without sedation.
Age in the registry: 6 years to 16 years · Sex: All
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Texas Southwestern Medical Center Coordinator of this site? Confirm its status | Dallas | United States | Unknown status |
| Columbia University Coordinator of this site? Confirm its status | New York | United States | Unknown status |
| Memorial Sloan-Kettering Cancer Center Coordinator of this site? Confirm its status | New York | United States | Unknown status |
| Seattle Children's Hospital Coordinator of this site? Confirm its status | Seattle | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.